ACHP supports the Administration’s health care modernization and digital transformation initiatives to make the prior authorization process less burdensome for payers and providers and avoid care delays for patients.
ACHP’s comments on the 2024 Medicare Advantage Advance Notice include strong support for policies improving access and competition.
ACHP joined a coalition in submitting comments in response to proposed rulemaking on substance use disorder patient records from HHS, OCR and SAMHSA.
ACHP submitted a comment letter to USPTO with recommendations to ensure reliability of patent rights and address the high cost of drugs.
ACHP included recommendations to improve consumer experience in a letter to CMS in response to HHS Notice of Benefit and Payment Parameters.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.
